Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1983 Mar;14(3):191–195. doi: 10.1007/BF00205359

The use of cellular immunoadsorbents to prepare polyclonal antibodies that distinguish between antigens derived from human melanoma cells and autologous lymphocytes

Peter J Kelleher 1, Herbert L Mathews 1, George E Moore 1,3, Percy Minden 1,
PMCID: PMC11039103  PMID: 6601511

Abstract

Cellular immunoadsorbents were employed to isolate xenogeneic antibodies that reacted with a restricted group of antigens on human melanoma cells. Melanoma cells and autologous lymphoid cells were grown in tissue culture. Cellular immunoadsorbents were prepared by coupling formalin-treated melanoma and lymphoid cells to diethylaminoethyl cellulose. Rabbits were immunized with melanoma cells and antisera were passed sequentially through immunoadsorbents made of fetal bovine serum, and lymphoid cells. Unbound effluents were then passed through an immunoadsorbent prepared with melanoma cells. Antibodies binding to melanoma cells were eluted and their reactivity to melanoma-derived antigens was tested using a solid-phase radioimmunoassay. Antigens for this assay were NP-40 lysates of melanoma and lymphoid cells and fetal bovine serum. Radioactive Staphylococcal protein A was used to detect binding by the antibodies to the test antigens.

The effects of formalin-fixation and storage of melanoma and lymphoid cells were studied. Storage of fixed melanoma cells for periods up to 4 months did not affect their capacity to bind antibodies. A single exposure of formalin-fixed cells to a low-pH elution buffer which was followed by neutralization did not affect binding by these cells. Antibodies isolated in this manner were of the IgG class and reacted with antigens derived from melanoma cells but not from autologous lymphocytes or fetal bovine serum. This study demonstrated the feasibility of using cellular immunoadsorbents to prepare xenogeneic polyclonal antibodies with a high degree of reactivity to antigens derived from human melanoma cells.

Keywords: Cellulose, Melanoma, Fetal Bovine Serum, Tissue Culture, Polyclonal Antibody

Footnotes

Abbreviations used in this paper: TAA, tumor-associated antigens; 125I-SPA, radiolabeled Staphylococcal protein A; FBS, fetal bovine serum; PBS, phosphate-buffered saline; BB, borate buffer; SPA, solid-phase assay; anti-mel, antibodies to melanoma cells; anti-mel(FBS), anti-mel absorbed with FBS; PAM, ‘purified’ anti-mel(FBS); IgG, immunoglobulin G; PVC, polyvinyl chloride.

References

  • 1.Avrameas S, Ternynck T. The crosslinking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. Immunochemistry. 1969;6:53. doi: 10.1016/0019-2791(69)90178-5. [DOI] [PubMed] [Google Scholar]
  • 2.Brown JP, Wright PW, Hart CE, Woodbury RG, Hellström KE, Hellström I. Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies. J Biol Chem. 1980;225:4980. [PubMed] [Google Scholar]
  • 3.Bruggen J, Sorg C, Macher E. Membrane-associated antigens of human malignant melanoma. V. Serological typing of cell lines using antisera from nonhuman primates. Cancer Immunol Immunother. 1978;5:53. [Google Scholar]
  • 4.Carrel S, Accolla RS, Carmagnola AL, Mach JP. Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res. 1980;40:2523. [PubMed] [Google Scholar]
  • 5.Colcher D, Hand PH, Nati M, Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA. 1981;78:3199. doi: 10.1073/pnas.78.5.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dennick RG, Price MR. Factors influencing the antigenicity and immunogenicity of radiation-attentuated amino-azo dye-induced rat hepatoma cells. Br J Cancer. 1978;38:183. [Google Scholar]
  • 7.Dippold WG, Lloyd KO, Li LT, Ikeda H, Oettgen HF, Old LJ. Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA. 1980;77:6114. doi: 10.1073/pnas.77.10.6114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ey PL, Prowse SJ, Jenkin CR. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978;15:429. doi: 10.1016/0161-5890(78)90070-6. [DOI] [PubMed] [Google Scholar]
  • 9.Farr RS. A quantitative immunochemical measure of the primary interaction between I* BSA and antibody. J Infect Dis. 1958;103:239. doi: 10.1093/infdis/103.3.239. [DOI] [PubMed] [Google Scholar]
  • 10.Irie RF, Irie K, Morton DL. Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J Natl Cancer Inst. 1974;52:1051. doi: 10.1093/jnci/52.4.1051. [DOI] [PubMed] [Google Scholar]
  • 11.Kelleher PJ, Mathews HL, Woods LK, Farr RS, Minden P. A solid-phase radioimmunoassay to detect antibodies produced by hybridomas to antigens derived from human melanoma cells. Cancer Immunol Immunother. 1983;14:185–190. doi: 10.1007/BF00205358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Koprowski H, Steplewski A, Herlyn D, Herlyn M. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA. 1978;75:3405. doi: 10.1073/pnas.75.7.3405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Liao S, Kwong PC, Thompson JC, Dent PB. Spectrum of melanoma antigens and cultured human malignant melanoma cells as detected by monkey antibodies. Cancer Res. 1979;39:189. [PubMed] [Google Scholar]
  • 14.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265. [PubMed] [Google Scholar]
  • 15.Mathews HL, Minden P. Purification of antibodies to bacterial antigens by an immunoadsorbent and a method to quantify their reaction with insoluble bacterial targets. J Immunol Methods. 1979;28:219. doi: 10.1016/0022-1759(79)90189-3. [DOI] [PubMed] [Google Scholar]
  • 16.Mathews HL, Brunda MJ, Minden P. The use of cellular immunoadsorbents to prepare antibody that distinguishes between syngeneic surface antigens on two guinea pig hepatocarcinomas. J Immunol. 1980;124:1141. [PubMed] [Google Scholar]
  • 17.McCabe RP, Quaranta V, Frugis L, Ferrone S, Reisfeld RA. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens. J Natl Cancer Inst. 1979;68:455. doi: 10.1093/jnci/62.3.455. [DOI] [PubMed] [Google Scholar]
  • 18.McKinney RM, Thacker L, Wong MC, Herbut GA. Improved immunoadsorption procedure with anion exchange bacterial cell columns. J Immunol Methods. 1978;21:1. doi: 10.1016/0022-1759(78)90218-1. [DOI] [PubMed] [Google Scholar]
  • 19.Metzgar RS, Mohanakumar T. Serological studies on the diagnosis and nosology of human leukemia. Am J Clin Pathol. 1977;68:699. [PubMed] [Google Scholar]
  • 20.Minden P, McClatchy JK, Wainberg M, Weiss DW. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells. J Natl Cancer Inst. 1974;53:1325. doi: 10.1093/jnci/53.5.1325. [DOI] [PubMed] [Google Scholar]
  • 21.Minden P, Sharpton TR, McClatchy JK. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG) J Immunol. 1976;116:1407. [PubMed] [Google Scholar]
  • 22.Quinn LA, Woods LK, Merrick SB, Arabasz NM, Moore GE. Cytogenetic analysis of twelve human malignant melanoma cell lines. J Natl Cancer Inst. 1977;59:301. [Google Scholar]
  • 23.Rockoff SD, McIntyre AH, Kaungs GL, Princler RB, Herberman RB, Larson JN. Sensitive and convenient quantitation of antibody binding to cellular antigens using glutaraldehyde preserved cells. J Immunol Methods. 1979;26:369. doi: 10.1016/0022-1759(79)90183-2. [DOI] [PubMed] [Google Scholar]
  • 24.Yeh MY, Hellström I, Brown JP, Warner GA, Hansen JA, Hellström KE. Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci USA. 1979;76:2927. doi: 10.1073/pnas.76.6.2927. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES